Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / LMDX - LumiraDx partners with Audere for solution to use with COVID-19 test

LMDX - LumiraDx partners with Audere for solution to use with COVID-19 test

LumiraDx Limited
LumiraDx (NASDAQ:LMDX) announces a partnership with digital health non-profit Audere, to offer a self-collected COVID-19 nasal specimen collection kit that has been authorized for use with the LumiraDx SARS-CoV-2 RNA STAR Complete assay to process self-collected samples. LMDX shares rise 5.7% premarket at $8.69. Laboratories utilizing the SARS-CoV-2 RNA STAR Complete will be able to integrate Audere's testing solution, HealthPulse@home into their systems. Using HealthPulse@home authorized labeling instructions, labs can provide their own specimen collection kit solution that fits into the lab's preference of kit registration, accessioning, and flexibility of shipping carriers. The HealthPulse@home solution is designed for efficiency and simplicity and requires no additional usability studies.

For further details see:

LumiraDx partners with Audere for solution to use with COVID-19 test
Stock Information
Company Name: LumiraDx Limited
Stock Symbol: LMDX
Market: NASDAQ
Menu
LMDX LMDX Quote LMDX Short LMDX News LMDX Articles LMDX Message Board
Get LMDX Alerts

News, Short Squeeze, Breakout and More Instantly...